Search Results - "Katz‐Agranov, Nurit"

Refine Results
  1. 1
  2. 2

    The microbiome and systemic lupus erythematosus by Katz-Agranov, Nurit, Zandman-Goddard, Gisele

    Published in Immunologic research (01-04-2017)
    “…The microbiota, which is comprised of the collective of all microbes inhabiting the gut and its effect on the human host in which it resides, has become a…”
    Get full text
    Journal Article
  3. 3

    Brief Report: Use and Side Effects of Sodium-Glucose Transporter 2 Inhibitors Among US People With HIV With Clinical Indications by Sise, Meghan E, Katz-Agranov, Nurit, Strohbehn, Ian A, Harden, Destiny, Moreno, Daiana, Durbin, Claudia, Toribio, Mabel, Neilan, Tomas G, Zanni, Markella V

    “…Sodium-glucose transporter 2 (SGLT2) inhibitors have been approved for treatment of diabetes mellitus (DM), chronic kidney disease, and heart failure, but…”
    Get full text
    Journal Article
  4. 4

    Severe esophageal injury after radiofrequency ablation-a deadly complication by Nurit Katz-Agranov Moises I Nevah Rubin

    Published in World journal of gastroenterology : WJG (14-05-2017)
    “…Various degrees of esophageal injury have been described after radiofrequency ablation performed for treatment of atrial fibrillation. The main mechanism of…”
    Get full text
    Journal Article
  5. 5

    Adverse kidney outcomes of CDK 4/6 inhibitors for metastatic breast cancer by Hanna, Paul E., Strohbehn, Ian A., Moreno, Daiana, Harden, Destiny, Seethapathy, Rituvanthikaa, Sawtell, Rani, Wang, Qiyu, Ouyang, Tianqi, Katz-Agranov, Nurit, Dinulos, James, Wander, Seth A., Gupta, Shruti, Sise, Meghan E.

    Published in NPJ breast cancer (19-08-2023)
    “…Cyclin-dependent kinase (CDK) 4/6 inhibitors have significantly improved overall and progression free survival of patients with metastatic breast cancer, but…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Are physicians overlooking the clinical assessment of hypovolemia? by Katz-Agranov, Nurit, MD, Akdam, Amir, MD, Stalnikowicz, Ruth, MD, Lernau, Omri, MD, Brezis, Mayer, MD, MPH

    Published in The American journal of emergency medicine (01-12-2015)
    “…The survey presented 3 clinical scripts suggestive of hypovolemia: (1) severe postural weakness in a patient recently treated with nonsteroidal…”
    Get full text
    Journal Article
  8. 8

    Autoimmunity and COVID-19 – The microbiotal connection by Katz-Agranov, Nurit, Zandman-Goddard, Gisele

    Published in Autoimmunity reviews (01-08-2021)
    “…The novel SARS-CoV-2 has been rattling the world since its outbreak in December 2019, leading to the COVID-19 pandemic. The learning curve of this new virus…”
    Get full text
    Journal Article
  9. 9

    The microbiome links between aging and lupus by Katz-Agranov, Nurit, Zandman-Goddard, Gisele

    Published in Autoimmunity reviews (01-03-2021)
    “…Many forms of immune dysregulation, which lead to inflammaging and senescence, have been demonstrated in patients with systemic lupus erythematosus (SLE;…”
    Get full text
    Journal Article
  10. 10

    The role of intravenous immunoglobulins in the treatment of rheumatoid arthritis by Katz-Agranov, Nurit, Khattri, Saakshi, Zandman-Goddard, Gisele

    Published in Autoimmunity reviews (01-08-2015)
    “…Abstract Intravenous immunoglobulins (IVIGs) are beneficial and safe for various diseases other than primary immunodeficiencies. Over the years, IVIG has been…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Kidney function in patients with ovarian cancer treated with poly (ADP-ribose) polymerase (PARP) inhibitors by Gupta, Shruti, Hanna, Paul E, Ouyang, Tianqi, Yamada, Karla Sofia, Sawtell, Rani, Wang, Qiyu, Katz-Agranov, Nurit, Feghali, Lea, Krasner, Carolyn N, Bouberhan, Sara, Castro, Cesar M, Sise, Meghan E

    “…Abstract Background Poly (ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the treatment of ovarian cancer; however, real-world data on kidney…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20